エピゲノム異常を標的とした子宮内膜癌の新たな診断・治療法の探索

Material type: 文書・図像類

Author: 阪埜, 浩司

Publisher: -

Publication date: 2018

Material Format: Digital

Capacity, size, etc.: -

NDC: -

View All

Notes on use

Note (General)：: type:text（１）腫瘍部において異常高メチル化を認める子宮内膜癌患者と認めない子宮内膜癌患者の末梢血DNAにおける遺伝子プロモーター領域のメチル化をゲノムワイドに比較した結果、Differentially Methylated CpG (DMC) およびDifferentially Methy...

Related materials as well as pre- and post-revision versions

科研費研究者番号 : 70265875

Search by Bookstore

Holdings of Libraries in Japan

This page shows libraries in Japan other than the National Diet Library that hold the material.

List of Cooperating Institutions and Databases

Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.

other

Keio Associated Repository of Academic resources
Digital
You can check the holdings of institutions and databases with which 学術機関リポジトリデータベース（IRDB）（機関リポジトリ） is linked at the site of 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）.
Keio Associated Repository of Academic resources

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type: 文書・図像類
Title: エピゲノム異常を標的とした子宮内膜癌の新たな診断・治療法の探索
Author/Editor: 阪埜, 浩司
Author Heading: 阪埜, 浩司
Publication Date: 2018
Publication Date (W3CDTF): 2018
Alternative Title: エピゲノムイジョウオヒョウテキトシタシキュウナイマクガンノアラタナシンダン・チリョウホウノタンサク
Epigenomu ijō o hyōteki to shita shikyū naimakugan no aratana shindan chiryōhō no tansaku
The study of novel diagnosis and treatment for endometrial cancer targeting aberrant DNA methylation
Periodical title: 科学研究費補助金研究成果報告書
Text Language Code: jpn
eng
Subject Heading: 子宮内膜癌,異常メチル化,miR-663a,メトホルミン
Target Audience: 一般
Note (General): type:text
（１）腫瘍部において異常高メチル化を認める子宮内膜癌患者と認めない子宮内膜癌患者の末梢血DNAにおける遺伝子プロモーター領域のメチル化をゲノムワイドに比較した結果、Differentially Methylated CpG (DMC) およびDifferentially Methylated Region (DMR)としてmiR-663aを同定した。(２) プロゲスチン製剤および2型糖尿病薬を併用することにより、子宮内膜癌細胞に対し殺細胞効果が認められることをin vitroおよびin vivo実験にて明らかにした。 (1) Based on genome-wide bisulfite sequencing, peripheral blood cells(PBCs) DNA in M-H cases had significant hypermethylation in the miR-663a promoter region, compared to U cases (meth. Diff. > 25%, q-value < 0.01). Consistent with this methylation status, miR-663a expression was lower in M-H PBCs than in U PBCs. DNMTs expression levels in M-H endometrial cancer were higher than those in U endometrial cancer. (2) Metformin had a dose-dependent anticancer effect on endometrial cancer cell lines. Moreover, the combined treatment also caused lower cell viability.The microarray analysis indicated that EDN2 expression was upregulated in cells subject to the combined treatment. EDN2 expression was upregulated in each cell line upon treatment with a demethylating agent.
研究種目 : 基盤研究(C)(一般) 研究期間 : 2016～2018 課題番号 : 16K11154 研究分野 : 婦人科腫瘍学
Source: https://koara.lib.keio.ac.jp/xoonips/modules/xoonips/download.php?koara_id=KAKEN_16K11154seika
https://koara.lib.keio.ac.jp/xoonips/modules/xoonips/download.php?koara_id=KAKEN_16K11154seika
Access Restrictions: 限定公開
Related Material: 科研費研究者番号 : 70265875
Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）
https://irdb.nii.ac.jp
Original Data Provider (Database): 慶應義塾大学 : 慶應義塾大学学術情報リポジトリ